Innovative Procedure of Mesothelioma Biopsy Bears Accurate Result without Involving Invasive Surgery
A new study that focuses on innovative procedure of mesothelioma biopsy bears promising results for anyone that may potentially contract malignant pleural mesothelioma. There was a time when patients of this kind of disease must go through diagnostic surgical procedure that’s invasive just to make it sure that the cancer does indeed present. Today, new technology that’s not so invasive bears accurate results. Another advantage to expect from this procedure is less harmful side effects.
The study was published in CardioVascular and Interventional Radiology journal recently. It explored the possible role of biopsies that is guided by percutaneous image to detect the presence of malignant pleural mesothelioma, which is a dangerously fatal and rare type of cancer with asbestos exposure as its only known cause. Traditional procedure to confirm this cancer’s presence usually makes use of thoracoscopy method and, at times, an open surgery to take some tissue samples from the chest. These procedures pose some negative side effects: they are uncomfortable for the patients and expensive too. Plus, these procedures might trigger spreading of the cancer cells to the areas that were previously cancer-free.
Read also: Mesothelioma as a Notorious Cause of Death
Mayo Clinic researchers examined the results coming from 32 patients—who have been tested positive for malignant pleural mesothelioma confirmed through percutaneous image-guided biopsies. The procedure involves a biopsy needle that’s automated. Physicians use this needle together with ultrasound imaging. Patients do not need to stay in the hospital overnight and the procedure doesn’t involve chest tube fitted to them after the biopsies.
The study showed that the automated biopsy provides patients with comfort and decrease in pain level and disruption as well as increasing diagnosis accuracy as high as 81%. Above all, the procedure prohibits the cancer cells from getting transferred into the site of surgery, preventing the disease from spreading. The authors on the study state that the study proves that percutaneous image-guided biopsy to detect the presence of malignant pleural mesothelioma corresponds with absolutely low rates of complication, rates of tract seeding that are negligible, and average sensitivity. Percutaneous image-guided biopsy could be considered more reasonable, more affordable, and less invasive when it comes to obtaining histologic confirmation to the presence of malignant pleural mesothelioma. It also eliminates further intervention in a lot of patients.
Those who are diagnosed with mesothelioma already deal with so many things at once without having to take a procedure that is expensive and perhaps also unneeded. The study into new way of obtaining histologic confirmation can be the first step to eliminate things that affect life quality in a great way and, in addition, high cost.